Ramelteon and Hydroxyurea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ramelteon (ramelteon) and Hydroxyurea (hydroxyurea). Common drug interactions include death among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Ramelteon and Hydroxyurea. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Ramelteon?

Ramelteon has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 1,387 Ramelteon users. Check the latest studies of Ramelteon.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.

On Aug, 08, 2026

13 people who take Ramelteon and Hydroxyurea together, and have interactions are studied.

Ramelteon and Hydroxyurea drug interactions.

What are the common drug interactions of Ramelteon and Hydroxyurea, by gender? *:

female:

Death
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Failure to thrive (inadequate weight gain and physical growth in children)
Ocular icterus (presence of jaundice seen in the sclera of the eye)
Pericarditis (inflammation of the pericardium)
Peripheral swelling
Rosacea (a skin condition that causes facial redness)
White blood cell disorder
Fungal sepsis (whole body infection by fungus)

male:

Dehydration (dryness resulting from the removal of water)
Diarrhoea
Fatigue (feeling of tiredness)
Syncope (loss of consciousness with an inability to maintain postural tone)
Febrile neutropenia (fever with reduced white blood cells)
Mucosal inflammation (infection of mucous membrane)
Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
Rash

What are the common drug interactions of Ramelteon and Hydroxyurea, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Febrile neutropenia (fever with reduced white blood cells)
Mucosal inflammation (infection of mucous membrane)
Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
Rash

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Fungal sepsis (whole body infection by fungus)
Diarrhoea
Pericarditis (inflammation of the pericardium)
Peripheral swelling
Rosacea (a skin condition that causes facial redness)
White blood cell disorder
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Syncope (loss of consciousness with an inability to maintain postural tone)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 69.23%
High Blood Pressure: 6 people, 46.15%
Neuropathy Peripheral (surface nerve damage): 5 people, 38.46%
Adverse Event: 5 people, 38.46%
Back Pain: 5 people, 38.46%
Constipation: 5 people, 38.46%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 38.46%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 38.46%
White Blood Cell Count Increased: 5 people, 38.46%
Type 2 Diabetes: 5 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Ramelteon and Hydroxyurea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously